ARTICLE | Distillery Therapeutics
Cancer
April 4, 2017 10:08 PM UTC
Mouse studies suggest combining MSN inhibition with adoptive T cell therapy could help treat melanoma. In a mouse model of melanoma receiving mouse CD8+ T cells expressing a melanoma antigen, systemic...
BCIQ Company Profiles
BCIQ Target Profiles